Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis

INTRODUCTION: We previously demonstrated that HER2/neu-driven mammary carcinogenesis can be prevented by an interleukin-12 (IL-12)-adjuvanted allogeneic HER2/neu-expressing cell vaccine. Since IL-12 can induce the release of interleukin-15 (IL-15), in the present study we investigated the role playe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res
Main Authors: Croci, Stefania, Nanni, Patrizia, Palladini, Arianna, Nicoletti, Giordano, Grosso, Valentina, Benegiamo, Giorgia, Landuzzi, Lorena, Lamolinara, Alessia, Ianzano, Marianna L., Ranieri, Dario, Dall’Ora, Massimiliano, Iezzi, Manuela, De Giovanni, Carla, Lollini, Pier-Luigi
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4462012/
https://ncbi.nlm.nih.gov/pubmed/25997501
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-015-0588-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados